Target intelligence / Profile preview

Proline rich 13 pseudogene 2 (PRR13P2)

Target: PRR13P2
Molecular classification: Other (pseudogene)

Overview

Proline rich 13 pseudogene 2 (PRR13P2) is a human pseudogene locus classified under noncoding DNA. Pseudogenes are genomic sequences with high homology to protein-coding genes but carry sequence disruptions (frameshifts, premature stop codons) preventing their translation into functional proteins[1][6][4][3]. PRR13P2 does not appear to be transcribed or play any recognized biological function. As with other pseudogenes, its presence reflects evolutionary genomic history, and it is not considered a drug discovery target, receptor, enzyme, or biomarker for disease or therapy[1][6][4].

Beyond the preview

Go deeper on Proline rich 13 pseudogene 2 (PRR13P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline rich 13 pseudogene 2 (PRR13P2).

Explore the full profile